0001179110-19-008315.txt : 20190702
0001179110-19-008315.hdr.sgml : 20190702
20190702133932
ACCESSION NUMBER: 0001179110-19-008315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190702
DATE AS OF CHANGE: 20190702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryll Thomas
CENTRAL INDEX KEY: 0001701531
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 19936405
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
FORM 4 -
X0306
4
2019-07-01
0
0000855654
IMMUNOGEN INC
IMGN
0001701531
Ryll Thomas
C/O IMMUNOGEN, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
VP, Technical Operations
Common Stock
2019-07-01
4
A
0
5230
1.84
A
92414
D
These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from January 1, 2019 through June 30, 2019.
In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2019.
/s/ Craig Barrows, attorney in fact
2019-07-02